Efficacy and tolerability of ethionamide versus prothionamide: a systematic review

Affiliations

• ¹ MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease, Paris, France The Global Fund to Fight AIDS, Tuberculosis and Malaria, Geneva, Switzerland These authors contributed equally.
• ² MDR-TB Unit, Tuberculosis Division, International Union against Tuberculosis and Lung Disease, Paris, France Pneumology Dept, General Hospital of Gran Canaria "Dr. Negrin", Las Palmas, Spain These authors contributed equally.
• ³ Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari, Medical Education and Professional Development Unit, Sassari, Italy These authors contributed equally.
• ⁴ WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy.
• ⁵ WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy Public Health Consulting Group, Lugano, Switzerland.
• ⁶ WHO Collaborating Centre for TB and Lung Diseases, Fondazione S. Maugeri, Tradate, Italy giovannibattista.migliori@fsm.it.